Inventiva announced that, effective on November 9th, 2022, Inventiva's board of directors coopted Dr. Lucy Lu as the Director of its Board of Directors in lieu of Sofinnova Partners. The nomination of Dr. Lucy Lu will be submitted for ratification by the shareholders during the next general shareholders meeting. Dr. Lucy Lu has been Sofinnova Partners representative at Inventiva's Board of Directors since January 4th, 2020. Dr. Lu has over 20 years of extensive experience in the biotechnology and healthcare industries as an investment banker, financial analyst and executive.

Dr. Lu is the Chief Operations Officer at Innovative Cellular Therapeutics and prior to this role she served as President and CEO of Avenue Therapeutics. Dr. Lu also worked as a senior biotechnology analyst for Citigroup Inc. and holds an M.D. degree from the New York University School of Medicine.